Conclusions
resected stage IIIB-C, cutaneous melanoma
CUTANEOUS MELANOMA
In patients with resected stage IIIB-C cutaneous melanoma in this ITC, nivolumab improved RFS versus placebo and ipilimumab, and OS versus placebo after post-recurrence survival adjustment.